Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: Potential interaction with A2A and D2-like receptors

Sarah K. Leonard, Penelope Ferry-Leeper, Richard B. Mailman

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Whereas structurally dissimilar D1 antagonists competing for [3H]-SCH23390 binding recognize primarily one site in striatum, two distinct affinity states are observed in both amygdala and hippocampus. The binding profile of SCH23390 is similar in both of these regions, with the high affinity site (KD ∼ 0.4 nM) consistent with D1/D5 receptors. The appearance of the low affinity site (KD ∼ 300 nM) is dependent upon the absence of MgCl2, but independent of D1 expression (i.e., still present in D1 knockout mice). Although the density of high affinity state receptor is lower in hippocampus or amygdala of D1 knockout mice, some residual binding remains, consistent with the known expression of D5 receptors in these regions. Remarkably, in hippocampus, the affinity of the low affinity site is shifted rightward in the presence of the D2 antagonist domperidone and is largely absent in the hippocampus of D2 knockout animals. Additionally, this site is also shifted rightward in the presence of the A2A ligands SCH58261, CSC, or NECA, or in the absence of A2A receptors. The affinity of SCH23390 for this low affinity site is greater than seen for SCH23390 binding to D2 receptors in heterologous expression systems, consistent with the hypothesis that both D2 and A2A receptors are involved in the low affinity binding site. Therefore, we suggest that the heteromerization of D2 and A2A receptors reported previously in vitro also may occur in the brain of both rats and mice.

Original languageEnglish (US)
Pages (from-to)25-37
Number of pages13
JournalBrain research
Volume1117
Issue number1
DOIs
StatePublished - Oct 30 2006

Fingerprint

Rodentia
Hippocampus
Brain
Amygdala
Knockout Mice
Adenosine-5'-(N-ethylcarboxamide)
Domperidone
Magnesium Chloride
Binding Sites
Ligands
SCH 23390

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Molecular Biology
  • Clinical Neurology
  • Developmental Biology

Cite this

@article{46c1a0ae96f44a65a68fec6da1b7d161,
title = "Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain: Potential interaction with A2A and D2-like receptors",
abstract = "Whereas structurally dissimilar D1 antagonists competing for [3H]-SCH23390 binding recognize primarily one site in striatum, two distinct affinity states are observed in both amygdala and hippocampus. The binding profile of SCH23390 is similar in both of these regions, with the high affinity site (KD ∼ 0.4 nM) consistent with D1/D5 receptors. The appearance of the low affinity site (KD ∼ 300 nM) is dependent upon the absence of MgCl2, but independent of D1 expression (i.e., still present in D1 knockout mice). Although the density of high affinity state receptor is lower in hippocampus or amygdala of D1 knockout mice, some residual binding remains, consistent with the known expression of D5 receptors in these regions. Remarkably, in hippocampus, the affinity of the low affinity site is shifted rightward in the presence of the D2 antagonist domperidone and is largely absent in the hippocampus of D2 knockout animals. Additionally, this site is also shifted rightward in the presence of the A2A ligands SCH58261, CSC, or NECA, or in the absence of A2A receptors. The affinity of SCH23390 for this low affinity site is greater than seen for SCH23390 binding to D2 receptors in heterologous expression systems, consistent with the hypothesis that both D2 and A2A receptors are involved in the low affinity binding site. Therefore, we suggest that the heteromerization of D2 and A2A receptors reported previously in vitro also may occur in the brain of both rats and mice.",
author = "Leonard, {Sarah K.} and Penelope Ferry-Leeper and Mailman, {Richard B.}",
year = "2006",
month = "10",
day = "30",
doi = "10.1016/j.brainres.2006.08.024",
language = "English (US)",
volume = "1117",
pages = "25--37",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain : Potential interaction with A2A and D2-like receptors. / Leonard, Sarah K.; Ferry-Leeper, Penelope; Mailman, Richard B.

In: Brain research, Vol. 1117, No. 1, 30.10.2006, p. 25-37.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Low affinity binding of the classical D1 antagonist SCH23390 in rodent brain

T2 - Potential interaction with A2A and D2-like receptors

AU - Leonard, Sarah K.

AU - Ferry-Leeper, Penelope

AU - Mailman, Richard B.

PY - 2006/10/30

Y1 - 2006/10/30

N2 - Whereas structurally dissimilar D1 antagonists competing for [3H]-SCH23390 binding recognize primarily one site in striatum, two distinct affinity states are observed in both amygdala and hippocampus. The binding profile of SCH23390 is similar in both of these regions, with the high affinity site (KD ∼ 0.4 nM) consistent with D1/D5 receptors. The appearance of the low affinity site (KD ∼ 300 nM) is dependent upon the absence of MgCl2, but independent of D1 expression (i.e., still present in D1 knockout mice). Although the density of high affinity state receptor is lower in hippocampus or amygdala of D1 knockout mice, some residual binding remains, consistent with the known expression of D5 receptors in these regions. Remarkably, in hippocampus, the affinity of the low affinity site is shifted rightward in the presence of the D2 antagonist domperidone and is largely absent in the hippocampus of D2 knockout animals. Additionally, this site is also shifted rightward in the presence of the A2A ligands SCH58261, CSC, or NECA, or in the absence of A2A receptors. The affinity of SCH23390 for this low affinity site is greater than seen for SCH23390 binding to D2 receptors in heterologous expression systems, consistent with the hypothesis that both D2 and A2A receptors are involved in the low affinity binding site. Therefore, we suggest that the heteromerization of D2 and A2A receptors reported previously in vitro also may occur in the brain of both rats and mice.

AB - Whereas structurally dissimilar D1 antagonists competing for [3H]-SCH23390 binding recognize primarily one site in striatum, two distinct affinity states are observed in both amygdala and hippocampus. The binding profile of SCH23390 is similar in both of these regions, with the high affinity site (KD ∼ 0.4 nM) consistent with D1/D5 receptors. The appearance of the low affinity site (KD ∼ 300 nM) is dependent upon the absence of MgCl2, but independent of D1 expression (i.e., still present in D1 knockout mice). Although the density of high affinity state receptor is lower in hippocampus or amygdala of D1 knockout mice, some residual binding remains, consistent with the known expression of D5 receptors in these regions. Remarkably, in hippocampus, the affinity of the low affinity site is shifted rightward in the presence of the D2 antagonist domperidone and is largely absent in the hippocampus of D2 knockout animals. Additionally, this site is also shifted rightward in the presence of the A2A ligands SCH58261, CSC, or NECA, or in the absence of A2A receptors. The affinity of SCH23390 for this low affinity site is greater than seen for SCH23390 binding to D2 receptors in heterologous expression systems, consistent with the hypothesis that both D2 and A2A receptors are involved in the low affinity binding site. Therefore, we suggest that the heteromerization of D2 and A2A receptors reported previously in vitro also may occur in the brain of both rats and mice.

UR - http://www.scopus.com/inward/record.url?scp=33749997794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749997794&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2006.08.024

DO - 10.1016/j.brainres.2006.08.024

M3 - Article

C2 - 16962565

AN - SCOPUS:33749997794

VL - 1117

SP - 25

EP - 37

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -